Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Diodati, Lucrezia"" wg kryterium: Autor


Tytuł :
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients
Autorzy :
Del Re, Marzia
Bertolini, Ilaria
Crucitta, Stefania
Fontanelli, Lorenzo
Rofi, Eleonora
De Angelis, Claudia
Diodati, Lucrezia
Cavallero, Diletta
Gianfilippo, Giulia
Salvadori, Barbara
Fogli, Stefano
Falcone, Alfredo
Scatena, Cristian
Naccarato, Antonio Giuseppe
Roncella, Manuela
Ghilli, Matteo
Morganti, Riccardo
Fontana, Andrea
Danesi, Romano
Pokaż więcej
Źródło :
Breast Cancer Research and Treatment. 178(1):57-62
Czasopismo naukowe
Tytuł :
Androgen receptor expression inversely correlates with histological grade and N stage in ER male breast cancer.
Autorzy :
Scatena C; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. .
Scarpitta R; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Innocenti L; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Miccoli M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Biancotti R; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Diodati L; Oncology Unit 2, Pisa University Hospital, Pisa, Italy.
Ghilli M; Breast Surgery Unit, Pisa University Hospital, Pisa, Italy.
Naccarato AG; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Jul; Vol. 182 (1), pp. 55-65. Date of Electronic Publication: 2020 May 21.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor/*metabolism
Breast Neoplasms, Male/*pathology
Receptor, ErbB-2/*metabolism
Receptors, Androgen/*metabolism
Receptors, Estrogen/*metabolism
Receptors, Progesterone/*metabolism
Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms, Male/metabolism ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Autorzy :
Cazzaniga M; Research Unit Phase I trials, ASST Monza, Monza, Italy.; Oncology Unit, ASST Monza, Monza, Italy.
Verusio C; Oncology Unit, ASST della Valle Olona-Presidio Ospedaliero di Saronno, Saronno, Italy.
Ciccarese M; Oncology Unit, Ospedale 'Vito Fazzi' di Lecce, Lecce, Italy.
Fumagalli A; Oncology Unit, Ospedale Moriggia Pelascini, Gravedona, Italy.
Sartori D; Oncology Unit, AULSS 3, Mirano, Italy.
Valerio MR; Oncology Department, Policlinico di Palermo Paolo Giaccone, Palermo, Italy.
Airoldi M; Oncology Unit 2-Città della Salute e della Scienza di Torino, Torino, Italy.
Moretti G; Oncology Unit, IRCCS Arcispedale S. Maria Nuova, Reggio Emilia, Italy.
Ficorella C; Dipartimento di Scienze Cliniche Applicate e Biotecnologiche (DISCAB)-Università Degli Studi Dell'Aquila, L'Aquila, Italy.
Arcangeli V; Oncology Unit Rimini Azienda USL Romagna, Rimini, Italy.
Diodati L; Oncology Unit 2, Azienda Osp edaliera Universitaria Pisa via Roma 67, Pisa, Italy.
Zambelli A; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Febbraro A; Oncology Unit, Ospedale Sacro Cuore di Gesù, Fatebenefratelli, Benevento, Italy.
Generali D; Brest Unit, ASST di Cremona, Cremona, Italy.
Pistelli M; Oncology Unit, AOU Ospedali Riuniti Umberto I-GM Lancisi-G Salesi, Ancona, Italy.
Garrone O; Oncology Unit, AOS Croce e Carle Ospedale di Insegnamento, Cuneo, Italy.
Musolino A; Oncology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Vici P; Oncology Unit 2, Istituto Nazionale Tumori Regina Elena-IFO, Roma, Italy.
Maur M; Oncology Unit, Policlinico University Hospital of Modena, Modena, Italy.
Mentuccia L; Oncology Unit, ASL di Frosinone Osp. 'SS. Trinità', Sora, Italy.
La Verde N; Oncology Unit, ASST Fatebenefratelli Sacco Presidio Ospedaliero Fatebenefratelli, Milano, Italy.
Bianchi G; Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
Artale S; Oncology Departement, Ospedale di Gallarate ASST Valle Olona, Gallarate, Italy.
Blasi L; Oncology Unit, ARNAS Civico Palermo, Palermo, Italy.
Piezzo M; National Cancer Institute 'Fondazione Giovanni Pascale', Napoli, Italy.
Atzori F; Struttura Complessa di Oncologia Medica Azienda Ospedaliero-Universitaria Cagliari, Cagliari, Italy.
Turletti A; Oncology Unit, Ospedale Martini della ASL Città di Torino, Torino, Italy.
Benedetto C; Dipartimento Universitario Ginecologia e Ostetricia 1, Ospedale S. Anna Torino, Turin, Italy.
Cursano MC; Oncology Unit, Università Campus Bio-Medico, Roma, Italy.
Fabi A; Oncology Unit 1, Istituto Regina Elena-IFO, Roma, Italy.
Gebbia V; Oncology Unit, Ospedale La Maddalena, Palermo, Italy.
Schirone A; Oncolgy Department, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Palumbo R; Oncology Unit, IRCCS ICS Maugeri, Pavia, Italy.
Ferzi A; Oncology Unit, ASST OVEST Milanese, Presidio di Legnano, Legnano, Italy.
Frassoldati A; Oncology Unit, Az Ospedaliero Universitaria di Ferrara, Ferrara, Italy.
Scavelli C; Oncology Unit, Ospedale 'S. Cuore di Gesù', Gallipoli, Italy.
Clivio L; IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milano, Italy.
Torri V; IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milano, Italy.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2018 Nov 30; Vol. 9 (94), pp. 36720-36721. Date of Electronic Publication: 2018 Nov 30 (Print Publication: 2018).
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Autorzy :
Cazzaniga M; Research Unit Phase I trials, ASST Monza, Monza, Italy.; Oncology Unit, ASST Monza, Monza, Italy.
Verusio C; Oncology Unit, ASST della Valle Olona-Presidio Ospedaliero di Saronno, Saronno, Italy.
Ciccarese M; Oncology Unit, Ospedale 'Vito Fazzi' di Lecce, Lecce, Italy.
Fumagalli A; Oncology Unit, Ospedale Moriggia Pelascini, Gravedona, Italy.
Sartori D; Oncology Unit, AULSS 3, Mirano, Italy.
Valerio MR; Oncology Department, Policlinico di Palermo Paolo Giaccone, Palermo, Italy.
Airoldi M; Oncology Unit 2-Città della Salute e della Scienza di Torino, Torino, Italy.
Moretti G; Oncology Unit, IRCCS Arcispedale S. Maria Nuova, Reggio Emilia, Italy.
Ficorella C; Dipartimento di Scienze Cliniche Applicate e Biotecnologiche (DISCAB)-Università Degli Studi Dell'Aquila, L'Aquila, Italy.
Arcangeli V; Oncology Unit Rimini Azienda USL Romagna, Rimini, Italy.
Diodati L; Oncology Unit 2, Azienda Osp edaliera Universitaria Pisa via Roma 67, Pisa, Italy.
Zambelli A; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Febbraro A; Oncology Unit, Ospedale Sacro Cuore di Gesù, Fatebenefratelli, Benevento, Italy.
Generali D; Brest Unit, ASST di Cremona, Cremona, Italy.
Pistelli M; Oncology Unit, AOU Ospedali Riuniti Umberto I-GM Lancisi-G Salesi, Ancona, Italy.
Garrone O; Oncology Unit, AOS Croce e Carle Ospedale di Insegnamento, Cuneo, Italy.
Musolino A; Oncology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Vici P; Oncology Unit 2, Istituto Nazionale Tumori Regina Elena-IFO, Roma, Italy.
Maur M; Oncology Unit, Policlinico University Hospital of Modena, Modena, Italy.
Mentuccia L; Oncology Unit, ASL di Frosinone Osp. 'SS. Trinità', Sora, Italy.
La Verde N; Oncology Unit, ASST Fatebenefratelli Sacco Presidio Ospedaliero Fatebenefratelli, Milano, Italy.
Bianchi G; Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
Artale S; Oncology Departement, Ospedale di Gallarate ASST Valle Olona, Gallarate, Italy.
Blasi L; Oncology Unit, ARNAS Civico Palermo, Palermo, Italy.
Piezzo M; National Cancer Institute 'Fondazione Giovanni Pascale', Napoli, Italy.
Atzori F; Struttura Complessa di Oncologia Medica Azienda Ospedaliero-Universitaria Cagliari, Italy.
Turletti A; Oncology Unit, Ospedale Martini della ASL Città di Torino, Torino, Italy.
Benedetto C; Dipartimento Universitario Ginecologia e Ostetricia 1, Ospedale S. Anna Torino, Turin, Italy.
Cursano MC; Oncology Unit, Università Campus Bio-Medico, Roma, Italy.
Fabi A; Oncology Unit 1, Istituto Regina Elena-IFO, Roma, Italy.
Gebbia V; Oncology Unit, Ospedale La Maddalena, Palermo, Italy.
Schirone A; Oncolgy Department, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Palumbo R; Oncology Unit, IRCCS ICS Maugeri, Pavia, Italy.
Ferzi A; Oncology Unit, ASST OVEST Milanese, Presidio di Legnano, Legnano, Italy.
Frassoldati A; Oncology Unit, Az Ospedaliero Universitaria di Ferrara, Ferrara, Italy.
Scavelli C; Oncology Unit, Ospedale 'S. Cuore di Gesù', Gallipoli, Italy.
Clivio L; IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milano, Italy.
Torri On Behalf Of The Eva Study Group V; IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milano, Italy.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2018 Oct 02; Vol. 9 (77), pp. 34639-34640. Date of Electronic Publication: 2018 Oct 02 (Print Publication: 2018).
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Autorzy :
Cazzaniga M; Research Unit Phase I trials, ASST Monza, Monza, Italy.; Oncology Unit, ASST Monza, Monza, Italy.
Verusio C; Oncology Unit, ASST della Valle Olona-Presidio Ospedaliero di Saronno, Saronno, Italy.
Ciccarese M; Oncology Unit, Ospedale 'Vito Fazzi' di Lecce, Lecce, Italy.
Fumagalli A; Oncology Unit, Ospedale Moriggia Pelascini, Gravedona, Italy.
Sartori D; Oncology Unit, AULSS 3, Mirano, Italy.
Valerio MR
Ancona C; Oncology Department, Policlinico di Palermo Paolo Giaccone, Palermo, Italy.
Airoldi M; Oncology Unit 2-Città della Salute e della Scienza di Torino, Torino, Italy.
Moretti G; Oncology Unit, IRCCS Arcispedale S. Maria Nuova, Reggio Emilia, Italy.
Ficorella C; Dipartimento di Scienze Cliniche Applicate e Biotecnologiche (DISCAB)-Università Degli Studi Dell'Aquila, L'Aquila, Italy.
Arcangeli V; Oncology Unit Rimini Azienda USL Romagna, Rimini, Italy.
Diodati L; Oncology Unit 2, Azienda Osp edaliera Universitaria Pisa via Roma 67, Pisa, Italy.
Zambelli A; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Febbraro A; Oncology Unit, Ospedale Sacro Cuore di Gesù, Fatebenefratelli, Benevento, Italy.
Generali D; Brest Unit, ASST di Cremona, Cremona, Italy.
Pistelli M; Oncology Unit, AOU Ospedali Riuniti Umberto I-GM Lancisi-G Salesi, Ancona, Italy.
Garrone O; Oncology Unit, AOS Croce e Carle Ospedale di Insegnamento, Cuneo, Italy.
Musolino A; Oncology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Vici P; Oncology Unit 2, Istituto Nazionale Tumori Regina Elena-IFO, Roma, Italy.
Maur M; Oncology Unit, Policlinico University Hospital of Modena, Modena, Italy.
Mentuccia L; Oncology Unit, ASL di Frosinone Osp. 'SS. Trinità', Sora, Italy.
La Verde N; Oncology Unit, ASST Fatebenefratelli Sacco Presidio Ospedaliero Fatebenefratelli, Milano, Italy.
Bianchi G; Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
Artale S; Oncology Departement, Ospedale di Gallarate ASST Valle Olona, Gallarate, Italy.
Blasi L; Oncology Unit, ARNAS Civico Palermo, Palermo, Italy.
Piezzo M; National Cancer Institute 'Fondazione Giovanni Pascale', Napoli, Italy.
Atzori F; Struttura Complessa di Oncologia Medica Azienda Ospedaliero-Universitaria Cagliari, Italy.
Turletti A; Oncology Unit, Ospedale Martini della ASL Città di Torino, Torino, Italy.
Benedetto C; Dipartimento Universitario Ginecologia e Ostetricia 1, Ospedale S. Anna Torino, Turin, Italy.
Cursano MC; Oncology Unit, Università Campus Bio-Medico, Roma, Italy.
Fabi A; Oncology Unit 1, Istituto Regina Elena-IFO, Roma, Italy.
Gebbia V; Oncology Unit, Ospedale La Maddalena, Palermo, Italy.
Schirone A; Oncolgy Department, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
Palumbo R; Oncology Unit, IRCCS ICS Maugeri, Pavia, Italy.
Ferzi A; Oncology Unit, ASST OVEST Milanese, Presidio di Legnano, Legnano, Italy.
Frassoldati A; Oncology Unit, Az Ospedaliero Universitaria di Ferrara, Ferrara, Italy.
Scavelli C; Oncology Unit, Ospedale 'S. Cuore di Gesù', Gallipoli, Italy.
Clivio L; IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milano, Italy.
Torri On Behalf Of The Eva Study Group V; IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milano, Italy.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2018 Aug 07; Vol. 9 (61), pp. 31877-31887. Date of Electronic Publication: 2018 Aug 07 (Print Publication: 2018).
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies